6-BROMO-2,2-DIMETHYL-4H-BENZO[D][1,3]DIOXINE, 95.0%, 250mg

Glycyl-L-glutamic acid, 95%, 5g

(2-Methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methanol, 98%, 5g

(Z)-(2-Aminothiazol-4-yl)-methoxycarbonylmethoxyiminoacetic acid, 97.0%, 100g

2-(3,4-Dichlorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 5g

Methyl 3-((tert-Butyldimethylsilyl)oxy)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate, 98%, 250mg

1-Benzylpiperidine-2-carboxylic acid, 95.0%, 5g

4'-Demethylepipodophyllotoxin, 98%, 100mg

Flat flange reaction vial, cylindrical, graduated, with tempering jacket GL connecting piece, DN 150, 6000 ml, 190 mm, 1 Piece

2-(2-Cyclohexylethyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98%, 5g

2-Amino-5-methyl-1,7-dihydropyrrolo[2,3-d]pyrimidin-4-one, 97%, 100mg

(S)-tert-Butyl (2-amino-3-hydroxypropyl)carbamate, 97%, 1g

2-(6-Bromo-8-fluoro-3-quinolyl)acetonitrile, 98%, 100mg